Around 20–40% of the general population are estimated to have insulin resistance—a condition where insulin begins to be less ...

Diabetes is typically diagnosed through tests that measure blood sugar levels, with HbA1c and fasting plasma glucose (FPG) ...

This common blood test indicates whether or not your body has been coping well with sugar over the last few months.

Eli Lilly has positive phase 3 results for its triple agonist retatrutide in type 2 diabetes (T2D) to go with its earlier encouraging data as a weight-loss therapy.

A normal blood report does not always mean everything is fine. Hidden markers like hs-CRP, Lipoprotein(a), and HbA1c can reveal early metabolic and cardiovascular risks. Detecting these early allows ...

With the obesity numbers for Eli Lilly’s retatrutide already stacking up nicely, the company has rounded out its pitch for the triple agonist with top-line data on its ability to lower blood sugar ...

This month, the American Red Cross is encouraging more people to roll up their sleeves and donate blood by offering an ...

Should A1c remain the gold standard for routine monitoring of glucose control in people with diabetes, or is it time to shift ...

Our editors tested two popular glucose monitors to determine which is the best for improving ​​diet, sleep and exercise habits.

A workplace text over a routine medical act raises sharp questions about privacy, disability rights and who must adapt.

Tirzepatide provided a larger reduction in HbA1c and greater improvements in multiple cardiometabolic parameters compared with conventional care for adults recently diagnosed with type 2 diabetes, ...